Related Experiment Video
Updated: May 17, 2026

03:55
Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer
Published on: June 9, 2023
Differentiated thyroid cancer invading the hypopharynx: A case report
D A Chaukar1, S G Prabhudesai, N L Bhambhani
1Department of Surgical Oncology, Head and Neck Services, Tata Memorial Hospital, Parel, 400 012 Mumbai, India.
Summary
Thyroid cancer invasion of the hypopharynx is rare but treatable. Aggressive surgical resection, including partial pharyngectomy, offers a successful management strategy for this advanced thyroid carcinoma, leading to disease-free survival.
Area of Science:
- Oncology
- Surgical Oncology
- Head and Neck Surgery
Background:
- Well-differentiated thyroid cancers, comprising 90-95% of cases, are typically localized within the thyroid gland.
- Invasion into the upper aerodigestive tract is uncommon for these thyroid cancers.
- Hypopharyngeal invasion by thyroid carcinoma is a rare occurrence.
Purpose of the Study:
- To present a case of thyroid cancer with hypopharyngeal invasion.
- To describe the successful surgical management of this rare presentation.
- To advocate for aggressive surgical intervention in similar cases.
Main Methods:
- A 51-year-old male patient with thyroid cancer invading the hypopharynx was identified.
- The patient underwent complete surgical resection of the thyroid cancer.
- A partial pharyngectomy was performed as part of the surgical management.
Main Results:
- The patient achieved complete resection of the thyroid carcinoma.
- Post-surgery, the patient remains asymptomatic.
- The patient has been disease-free for eighteen months following the intervention.
Conclusions:
- Aggressive surgical extirpation is a viable and effective treatment for thyroid carcinoma invading the upper aerodigestive tract.
- Complete resection, including partial pharyngectomy when necessary, can lead to successful outcomes.
- This approach supports long-term disease-free survival in patients with advanced thyroid cancer.
More Related Videos
Related Concept Videos
Graves' Disease I: Introduction
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
Hyperthyroidism II: Pathophysiology
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
The Thyroid Gland
The thyroid gland is a small, butterfly-shaped gland located in the neck and covers the anterior surface of the trachea. The gland has two lateral lobes connected by a thin tissue mass called the isthmus. Internally, each lobe comprises many small spherical structures known as thyroid follicles, surrounded by a network of blood vessels.
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
Hyperthyroidism I: Introduction
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...

